Peptide stacks · Growth hormone
CJC-1295 and ipamorelin stack: what’s in it and the evidence
Checked against our library and study pagesPublished by PepVault
The CJC-1295 and ipamorelin stack is a blend of two compounds, CJC-1295 no DAC and ipamorelin, that the peptide community runs for growth hormone and body composition. The vial the library records holds 10 mg of powder in all: 5 mg each of CJC-1295 no DAC and ipamorelin.
This page describes what the crowd runs and what a vial holds. It recommends no stack and names no seller.
What’s in the CJC-1295 and ipamorelin stack
| Part | Amount | What it’s there for | Evidence (library) |
|---|---|---|---|
| CJC-1295 no DAC | 5 mg in the vial; 100–200 mcg per dose reported | GHRH analogue — pulsatile GH release, short half-life, stacks cleanly with GHRPs | Moderate |
| Ipamorelin | 5 mg in the vial; 200–300 mcg per dose reported | Selective GHRP — GH pulse without cortisol or prolactin rises in animal studies | Moderate |
What the 10 mg vial holds, part by part
CJC-1295 no DAC
In the CJC-1295 and ipamorelin stack, CJC-1295 no DAC is listed for “GHRH analogue — pulsatile GH release, short half-life, stacks cleanly with GHRPs”. The shorter-acting version of CJC-1295, meant to give sharp, pulse-like GH release.
Ipamorelin
In the CJC-1295 and ipamorelin stack, ipamorelin is listed for “Selective GHRP — GH pulse without cortisol or prolactin rises in animal studies”. Considered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides.

Has the CJC-1295 and ipamorelin stack been studied as a combination?
None of our 436 study pages tested CJC-1295 no DAC and ipamorelin together, so the CJC-1295 and ipamorelin stack rests on studies of its parts and on community reports.
What the library says about the evidence for the CJC-1295 and ipamorelin stack
This GHRH-analog + ghrelin-agonist pairing is reported to produce a roughly 3-5x larger GH pulse than either alone by acting on different pituitary receptors; it lacks formal combination safety trials but is widely described as well tolerated. CJC-1295 with DAC raised GH 2- to 10-fold for 6+ days after one injection (Teichman 2006); the no-DAC form used in this stack hasn't been studied in humans, and no trial has tested this specific combination. The foundational GH stack: CJC-1295 amplifies each GH pulse and ipamorelin triggers it without raising cortisol (in animal studies), so together they give a larger GH response than either alone.
The studies of the parts, one by one: 0 study pages on CJC-1295 no DAC (0 in people) and 10 study pages on ipamorelin (1 in people).
| Part | Study pages | In people | Strongest study page |
|---|---|---|---|
| CJC-1295 no DAC | 0 | 0 | None yet |
| Ipamorelin | 10 | 1 | Ipamorelin did not speed first meal after bowel surgery vs placebo (randomized trial, 2014) |
What people commonly report on the CJC-1295 and ipamorelin stack
Commonly reported: deeper sleep, recovery and body composition. Deeper sleep and better recovery than either alone.
These are reports from people who run it, collected in the library, not results from a trial and not a promise of what any one person will notice.
Why these are combined
The library gives two reasons for combining the parts of the CJC-1295 and ipamorelin stack:
- GHRH and GHRP signals together gave a larger GH pulse than either alone in human studies of related peptides (Bowers 1990); the dual signal matches how the pituitary is normally driven.
- In animal studies Ipamorelin triggered GH without raising cortisol or prolactin (human data cover GH only), so the pulse stays clean; water retention, tingling and glucose effects still apply.
From the library’s notes on the CJC-1295 and ipamorelin stack
The most widely used GH secretagogue pair: CJC-1295 no DAC (Mod GRF 1-29) gives the GHRH signal and Ipamorelin the GHRP signal. Pre-sleep and fasted-morning doses are most popular, and a high-fat meal within about 2 hours is commonly reported to blunt the pulse.
“CJC-1295 + Ipamorelin is the clean GH pulse”, the library’s note on the pair (clinical data)
CJC-1295 (no DAC) raises the GH baseline; Ipamorelin triggers a sharp, selective pulse without spiking cortisol or prolactin like older secretagogues. Timing matters more here than dose — fasted, before bed or post-workout, away from food (insulin + carbs blunt the pulse). The pairing mimics a natural release curve, which is the whole point of running them together.
“The core GH stack”, the Ipamorelin entry’s note (community report)
Mechanism: a GHRH (CJC) plus a GHRP (Ipa) releases more GH than the sum of each alone, a synergy well established for the drug classes in general.
“The core GH stack”, the CJC-1295 no DAC entry’s note (community report)
Mechanism: a GHRH analog (CJC) plus a GHRP (Ipa) releases more GH than the sum of each alone, a synergy well established for the two drug classes. CJC-1295 with DAC raised GH 2- to 10-fold (Teichman 2006); the no-DAC form hasn't been measured in humans.
How a the CJC-1295 and ipamorelin stack vial is mixed and measured
The vial the library records for the CJC-1295 and ipamorelin stack holds 10 mg of powder, mixed with 2 mL of bacteriostatic water. Every part dissolves into the same water, so each mL holds 2.5 mg of CJC-1295 no DAC and 2.5 mg of ipamorelin.
| Part | In the vial | Share | Per mL | In 10 units (0.1 mL) |
|---|---|---|---|---|
| CJC-1295 no DAC | 5 mg | 50% | 2.5 mg | 250 mcg |
| Ipamorelin | 5 mg | 50% | 2.5 mg | 250 mcg |
The ratio is fixed at 1 to 1 (CJC-1295 no DAC and ipamorelin), so a draw that holds more of one part holds more of all of them; a pre-mixed vial can’t change one part on its own.
The arithmetic only divides what the vial holds by the water it is mixed with; it says nothing about what amount anyone should take.
Compared with running the parts apart
What the library says about the CJC-1295 and ipamorelin stack against its parts on their own:
- Usually sourced as separate vials and drawn into one syringe.
- Commonly reported: SubQ 2–3x daily, fasted or before sleep, with both peptides drawn into one syringe just before injecting; cycles of 8–12 weeks, then 4 weeks off.
- GHRH and GHRP signals together gave a larger GH pulse than either alone in human studies of related peptides (Bowers 1990); the dual signal matches how the pituitary is normally driven.
- The classic GH stack: CJC-1295 amplifies each GH pulse and ipamorelin triggers it, so together they give a larger pulse than either alone, without the cortisol rise of other GHRPs.
- Users commonly co-inject them from one syringe; no compatibility study has been published.
- Almost always stacked with Ipamorelin: together they release more GH than either alone, a synergy well established for the two drug classes.
Safety notes
The library’s combination safety note on the CJC-1295 and ipamorelin stack
The combined GH/IGF-1 elevation makes the individual considerations additive — transient water retention, flushing, tingling, and possible reductions in insulin sensitivity — so glucose/IGF-1 monitoring is a reasonable clinician discussion. Ipamorelin's selectivity (shown in animal studies) means cortisol/prolactin are not expected to rise.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Questions people ask
What is in the CJC-1295 and ipamorelin stack?
The CJC-1295 and ipamorelin stack is a blend of two compounds, CJC-1295 no DAC and ipamorelin, that the peptide community runs for growth hormone and body composition. The vial the library records holds 10 mg of powder in all: 5 mg each of CJC-1295 no DAC and ipamorelin.
Has the CJC-1295 and ipamorelin stack been studied together?
Not as a combination in any of our study pages: the CJC-1295 and ipamorelin stack rests on studies of its parts and on community reports. From the library: This GHRH-analog + ghrelin-agonist pairing is reported to produce a roughly 3-5x larger GH pulse than either alone by acting on different pituitary receptors; it lacks formal combination safety trials but is widely described as well tolerated.
What do people report on the CJC-1295 and ipamorelin stack?
Commonly reported: deeper sleep, recovery and body composition. These are reports from people who run it.
How is a the CJC-1295 and ipamorelin stack vial measured?
The vial the library records holds 10 mg with 2 mL of water, at a fixed ratio, so one draw carries every part; the reconstitution calculator works out the units for a vial.
What does each part of the CJC-1295 and ipamorelin stack do?
The library lists CJC-1295 no DAC for “GHRH analogue — pulsatile GH release, short half-life, stacks cleanly with GHRPs” and ipamorelin for “Selective GHRP — GH pulse without cortisol or prolactin rises in animal studies”.
How does the CJC-1295 and ipamorelin stack compare with taking the parts separately?
From the library: Usually sourced as separate vials and drawn into one syringe.